HomeTITAN › Filing
🔔 Get instant alerts when TITAN files quarterly results on BSE Start free trial →

Investor Presentation - Institutional Investors & Analyst Meet 2026

Filed: 04 Jun 2026, 15:54 IST Exchange: BSE Category: General Update — Investor Presentation
Investor Presentation at Institutional Investors & Analyst Meet 2026 highlights Titan's multi-segment growth strategy. Key themes include premiumization, design innovation, and digital ecosystem expansion. EyeCare division targets 2.5x revenue growth by FY30 to ₹3,500 Cr. Jewellery division aims 2x revenue growth by FY30 with ~1,400 stores. International business, including Damas, targets strong growth with regional focus. Watches segment emphasizes design-led differentiation and premium retail scaling. Supply chain and manufacturing capabilities are being enhanced to support growth.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TITAN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TITAN to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Titan Company Limited

Important. The summary above is generated automatically from Titan Company Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.